BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cheng WL, Kao YH, Chen SA, Chen YJ. Pathophysiology of cancer therapy-provoked atrial fibrillation. Int J Cardiol 2016;219:186-94. [PMID: 27327505 DOI: 10.1016/j.ijcard.2016.06.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Lun R, Roy DC, Hao Y, Deka R, Huang W, Navi BB, Siegal DM, Ramsay T, Fergusson D, Shorr R, Dowlatshahi D. Incidence of stroke in the first year after diagnosis of cancer—A systematic review and meta-analysis. Front Neurol 2022;13:966190. [DOI: 10.3389/fneur.2022.966190] [Reference Citation Analysis]
2 Lun R, Siegal D, Ramsay T, Dowlatshahi D. Cancer and stroke: What do we know and where do we go? Thromb Res 2022;219:133-40. [PMID: 36179651 DOI: 10.1016/j.thromres.2022.09.014] [Reference Citation Analysis]
3 Bungo B, Chaudhury P, Arustamyan M, Rikhi R, Hussain M, Collier P, Kanj M, Khorana AA, Mentias A, Moudgil R. Better prediction of stroke in atrial fibrillation with incorporation of cancer in CHA2DS2VASC score: CCHA2DS2VASC score. IJC Heart & Vasculature 2022;41:101072. [DOI: 10.1016/j.ijcha.2022.101072] [Reference Citation Analysis]
4 Kumar M, Lopetegui-Lia N, Malouf CA, Almnajam M, Coll PP, Kim AS. Atrial fibrillation in older adults with cancer. J Geriatr Cardiol 2022;19:1-8. [PMID: 35233218 DOI: 10.11909/j.issn.1671-5411.2022.01.001] [Reference Citation Analysis]
5 Wajid S, Kauser S. Stroke risk assessment and atrial fibrillation (AF) in cancer patients. Cardiovascular toxicity and therapeutic modalities targeting cardio-oncology 2022. [DOI: 10.1016/b978-0-323-90461-2.00002-x] [Reference Citation Analysis]
6 Leiva O, AbdelHameid D, Connors JM, Cannon CP, Bhatt DL. Common Pathophysiology in Cancer, Atrial Fibrillation, Atherosclerosis, and Thrombosis: JACC: CardioOncology State-of-the-Art Review. JACC CardioOncol 2021;3:619-34. [PMID: 34988471 DOI: 10.1016/j.jaccao.2021.08.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 11.0] [Reference Citation Analysis]
7 Hussain M, Misbah R, Donnellan E, Alkharabsheh S, Hou Y, Cheng F, Crookshanks M, Watson CJ, Toth AJ, Houghtaling P, Moudgil R, Budd GT, Tang WHW, Kwon DH, Jaber W, Griffin B, Kanj M, Collier P. Impact of timing of atrial fibrillation, CHA2DS2-VASc score and cancer therapeutics on mortality in oncology patients. Open Heart 2020;7:e001412. [PMID: 33243931 DOI: 10.1136/openhrt-2020-001412] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Hajjar LA, Fonseca SMR, Machado TIV. Atrial Fibrillation and Cancer. Front Cardiovasc Med 2021;8:590768. [PMID: 34336939 DOI: 10.3389/fcvm.2021.590768] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Hajjar LA, Costa IBSDSD, Lopes MACQ, Hoff PMG, Diz MDPE, Fonseca SMR, Bittar CS, Rehder MHHDS, Rizk SI, Almeida DR, Fernandes GDS, Beck-da-Silva L, Campos CAHM, Montera MW, Alves SMM, Fukushima JT, Santos MVCD, Negrão CE, Silva TLFD, Ferreira SMA, Malachias MVB, Moreira MDCV, Valente Neto MMR, Fonseca VCQ, Soeiro MCFA, Alves JBS, Silva CMPDC, Sbano J, Pavanello R, Pinto IMF, Simão AF, Dracoulakis MDA, Hoff AO, Assunção BMBL, Novis Y, Testa L, Alencar Filho AC, Cruz CBBV, Pereira J, Garcia DR, Nomura CH, Rochitte CE, Macedo AVS, Marcatti PTF, Mathias Junior W, Wiermann EG, Val RD, Freitas H, Coutinho A, Mathias CMC, Vieira FMAC, Sasse AD, Rocha V, Ramires JAF, Kalil Filho R. Brazilian Cardio-oncology Guideline - 2020. Arq Bras Cardiol 2020;115:1006-43. [PMID: 33295473 DOI: 10.36660/abc.20201006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
10 Chang JH, Cheng CC, Lu YY, Chen YC, Chen SA, Chen YJ. Trastuzumab increases pulmonary vein arrhythmogenesis through modulating pulmonary vein electrical and conduction properties via phosphatidylinositol 3-kinase signaling. Iran J Basic Med Sci 2020;23:865-70. [PMID: 32774807 DOI: 10.22038/ijbms.2020.44651.10432] [Reference Citation Analysis]
11 曾 伟. Comparing the Molecular Biological Characteristics between Gastric Cancer and Atrial Fibrillation Based on mRNA Expression Profiles. HJCB 2020;10:1-14. [DOI: 10.12677/hjcb.2020.101001] [Reference Citation Analysis]
12 Enevoldsen C, Borregaard B, Riber SS, Riber LPS. Amiodarone for Postoperative Atrial Fibrillation in Lung Cancer Patients: A 6-Year Follow-Up Study. OJTS 2020;10:6-18. [DOI: 10.4236/ojts.2020.101002] [Reference Citation Analysis]
13 Fabiani I, Colombo A, Bacchiani G, Cipolla CM, Cardinale DM. Incidence, Management, Prevention and Outcome of Post-Operative Atrial Fibrillation in Thoracic Surgical Oncology. J Clin Med 2019;9:E37. [PMID: 31878032 DOI: 10.3390/jcm9010037] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
14 Abdel-Qadir H, Thavendiranathan P, Fung K, Amir E, Austin PC, Anderson GS, Lee DS. Association of Early-Stage Breast Cancer and Subsequent Chemotherapy With Risk of Atrial Fibrillation. JAMA Netw Open 2019;2:e1911838. [PMID: 31539076 DOI: 10.1001/jamanetworkopen.2019.11838] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
15 Yuan M, Zhang Z, Tse G, Feng X, Korantzopoulos P, Letsas KP, Yan BP, Wu WKK, Zhang H, Li G, Liu T, Xia Y. Association of Cancer and the Risk of Developing Atrial Fibrillation: A Systematic Review and Meta-Analysis. Cardiol Res Pract 2019;2019:8985273. [PMID: 31110819 DOI: 10.1155/2019/8985273] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
16 Chu G, Versteeg HH, Verschoor AJ, Trines SA, Hemels MEW, Ay C, Huisman MV, Klok FA. Atrial fibrillation and cancer - An unexplored field in cardiovascular oncology. Blood Rev 2019;35:59-67. [PMID: 30928168 DOI: 10.1016/j.blre.2019.03.005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 13.3] [Reference Citation Analysis]
17 Vedovati MC, Giustozzi M, Verdecchia P, Pierpaoli L, Conti S, Verso M, Di Filippo F, Marchesini E, Bogliari G, Agnelli G, Becattini C. Patients with cancer and atrial fibrillation treated with doacs: A prospective cohort study. Int J Cardiol 2018;269:152-7. [PMID: 30077526 DOI: 10.1016/j.ijcard.2018.07.138] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
18 Mantha S, Gupta D, Salmane C, Khaddr M, Soff GA, Steingart R. Anticoagulation in the Patient with Cancer. In: Lau JF, Barnes GD, Streiff MB, editors. Anticoagulation Therapy. Cham: Springer International Publishing; 2018. pp. 425-40. [DOI: 10.1007/978-3-319-73709-6_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Fitzpatrick T, Carrier M, Le Gal G. Cancer, atrial fibrillation, and stroke. Thromb Res 2017;155:101-5. [PMID: 28528288 DOI: 10.1016/j.thromres.2017.05.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 5.4] [Reference Citation Analysis]